-
Merz heads to Gulf as Germany looks to diversify trade ties
-
Selection process for future Olympic hosts set for reform
-
Serbian minister on trial over Trump-linked hotel plan
-
UK PM says Mandelson 'lied', regrets appointing him US envoy
-
Cochran-Siegle tops first Olympic downhill training
-
Gaza health officials say strikes kill 21 after Israel says shots wounded officer
-
Injured Vonn's Olympic bid is 'inspirational', ski stars say
-
Albania arrests 20 for toxic waste trafficking
-
US-Africa trade deal renewal only 'temporary breather'
-
Mir sets pace on Sepang day two, Yamaha absent
-
Xi, Putin hail 'stabilising' China-Russia alliance
-
GSK boosted by specialty drugs, end to Zantac fallout
-
UK's ex-prince leaves Windsor home amid Epstein storm: reports
-
Sky is the limit for Ireland fly-half Prendergast, says captain Doris
-
Feyi-Waboso reminds England great Robinson of himself
-
Starmer faces MPs as pressure grows over Mandelson scandal
-
HRW urges pushback against 'aggressive superpowers'
-
Russia demands Ukraine give in as UAE talks open
-
Gaza civil defence says 17 killed in strikes after Israel says shots wounded officer
-
France's Kante joins Fenerbahce after Erdogan 'support'
-
CK Hutchison launches arbitration over Panama Canal port ruling
-
Stocks mostly rise as traders ignore AI-fuelled sell-off on Wall St
-
Acclaimed Iraqi film explores Saddam Hussein's absurd birthday rituals
-
On rare earth supply, Trump for once seeks allies
-
Ukrainian chasing sumo greatness after meteoric rise
-
Draper to make long-awaited return in Davis Cup qualifier
-
Can Ilia Malinin fulfil his promise at the Winter Olympics?
-
CK Hutchison begins arbitration against Panama over annulled canal contract
-
UNESCO recognition inspires hope in Afghan artist's city
-
Ukraine, Russia, US negotiators gather in Abu Dhabi for war talks
-
WTO must 'reform or die': talks facilitator
-
Doctors hope UK archive can solve under-50s bowel cancer mystery
-
Stocks swing following latest AI-fuelled sell-off on Wall St
-
Demanding Dupont set to fire France in Ireland opener
-
Britain's ex-prince Andrew leaves Windsor home: BBC
-
Coach plots first South Africa World Cup win after Test triumph
-
Spin-heavy Pakistan hit form, but India boycott risks early T20 exit
-
Japan eyes Premier League parity by aligning calendar with Europe
-
Whack-a-mole: US academic fights to purge his AI deepfakes
-
Love in a time of war for journalist and activist in new documentary
-
'Unprecedented mass killing': NGOs battle to quantify Iran crackdown scale
-
Seahawks kid Cooper Kupp seeks new Super Bowl memories
-
Thousands of Venezuelans march to demand Maduro's release
-
AI, manipulated images falsely link some US politicians with Epstein
-
Move on, says Trump as Epstein files trigger probe into British politician
-
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant
-
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets
-
Arteta backs Arsenal to build on 'magical' place in League Cup final
-
Evil Empire to underdogs: Patriots eye 7th Super Bowl
-
UBS grilled on Capitol Hill over Nazi-era probe
Chinese doctors implant pig liver in human for first time
Chinese doctors said Wednesday that they had transplanted a liver from a genetically modified pig into a brain-dead human for the first time, raising hopes of a live-saving donor option for patients in the future.
Pigs have emerged as the best animal organ donors, with several living patients in the United States having received pig kidneys or hearts in the last few years.
Livers have proved trickier -- and had not previously been tested out inside a human body.
But with a huge and growing demand for liver donations across the world, researchers hope that gene-edited pigs can offer at least temporary relief to seriously ill patients on long waiting lists.
Doctors at the Fourth Military Medical University in Xi'an, China, announced the field's latest breakthrough in a study in the journal Nature.
A liver from a miniature pig, which had six edited genes to make it a better donor, was transplanted into a brain-dead adult at the hospital on March 10, 2024, according to the study.
The trial was terminated after 10 days at the request of the family, the doctors said, adding that they had followed strict ethical guidelines.
- 'Bridge organ' -
The patient, whose name, gender and other details were not revealed, still had their original liver, receiving what is called an auxiliary transplant.
The hope is that this kind of transplant can serve as a "bridge organ" to support the existing liver of sick people waiting on a human donor.
Over the 10 days, the doctors monitored the liver's blood flow, bile production, immune response and other key functions.
The pig liver "functioned really well" and "smoothly secreted bile" as well as producing the key protein albumin, study co-author Lin Wang of the Xi'an hospital told a press conference.
"It's a great achievement" that could help people with liver problems in the future, he added.
Other researchers also hailed the breakthrough but emphasised that this early step could not confirm whether the pig organ would work as a replacement for human livers.
Transplants of livers have proved difficult because they carry out several different functions -- unlike hearts, for example, which simply pump blood, Lin said.
Livers filter the body's blood, breaking down things like drugs and alcohol, as well as producing bile that carries away waste and breaks down fats.
The pig liver produced far smaller amounts of bile and albumin than a human liver could achieve, Lin said.
More research is needed -- including studying the pig liver for more than 10 days, he added.
Next, the doctors plan to trial the gene-edited pig liver in a living human.
- 'Impressive' -
Oxford University transplantation professor Peter Friend, who was not involved in the study, said the results were "valuable and impressive".
However, "this is not a replacement for liver transplantation from human donors (at least in the near-term)," he told AFP in an email.
"This is a useful test of the compatibility of genetically modified livers with humans and points to a future in which such livers can provide support for patients in liver failure."
Lin emphasised that collaboration with US researchers was crucial.
"To be frank, we have learned quite a lot from all the research performed and investigated by the United States doctors," he said.
Last year, scientists at the University of Pennsylvania attached a pig liver to a brain-dead patient -- but instead of being transplanted, the organ remained outside the body.
Both US recipients of pig heart transplants died.
But Towana Looney, 53, is back home in Alabama after receiving a pig kidney on November 25, 2024.
M.Gameiro--PC